22nd Annual Meeting of the Society of Urologic OncologyDec 01, 2021 - Dec 03, 2021
Typically the Society of Urologic Oncology (SUO)'s mission is to enable qualified members mainly interested in the proper care of patients along with malignant GU conditions to meet with regards to discussion, development, in addition to implementation of tips to improve care.Washington Marriott Wardman Park, Washington, DC
MedTravelExpoDecember 6–9, 2021
4th International Exhibition for Medical and Wellness Services, Health Improvement and Medical Treatment. Medical Clinics, Health and Spa Resorts (MedTravelExpo) is an exhibition for medical and health-related services and health care technologies
Webinar: CEARH Economic Development for Health Care LeadersDecember 8, 2021
Understand what economic development (ED) is and why it is important for health care leadership to be aware of ED initiatives.US
National Rural EMS And Care ConferenceApril 19, 2022 - April 20, 2022
Rural communities are wonderful places to live and work, which is why approximately 57 million people – one in five Americans – call them home.US
Generic Drugs in the USAMore
The US generics market has been booming lately, with generic sales reaching $127 billion in 2020. The COVID-19 pandemic has been one of the incentives to change US pharmaceutical policy towards encouraging more generics to enter the market. The FDA has issued a Drug Competition Action Plan aimed at increasing the number of generics approved and reducing the burden on the healthcare system. US generic drugs market will continue to grow in the coming years, reaching $237 billion by 2025.
Should All Men with Type 2 Diabetes Be Routinely Prescribed Phosphodiesterase Type 5 Inhibitors?More
According to numerous clinical studies, many serious health problems in men have similar pathological processes at their core. Diseases such as type 2 diabetes (T2DM), insulin resistance, erectile dysfunction (ED), benign prostatic hyperplasia (BPH) and depression are in most cases accompanied by conditions such as endothelial dysfunction and inflammation. Endothelial dysfunction is an imbalance between the production of vasodilating, angioprotective, antiproliferative factors, on the one hand, and vasoconstrictive, prothrombotic, proliferative factors, on the other hand.